Taho Pharmaceuticals Ltd. (TPEX: 6467)
Health Care · Pharmaceuticals · TW
NT$225.00
-2.60% today · +36.0% 1Y
Taho Pharmaceuticals Ltd. (TPEX: 6467) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $368.78M.
Over the last twelve months the share price has gained 36.0%, trading between 100.50 and 302.00.
Tweenvest scores Taho Pharmaceuticals Ltd. across four factors: quality 36/100, value 89/100. Its strongest factor is value.
6467 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $368.78M
- Revenue (TTM)
- $62.27K
- P/E
- —
- EPS
- -4.58
- Dividend yield
- —
- Beta (5Y)
- -0.94
- 52-week high
- NT$302.00
- 52-week low
- NT$100.50
- Avg volume (3M)
- —
- Shares outstanding
- 52.41M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Verano Holdings Corp.CNSX: VRNO | $381.78M | CA$7.44 | -0.67% |
| Shinpoong Pharmaceutical Co.,LtdKOSE: A019170 | $375.67M | ₩9,780.00 | +5.73% |
| Honz Pharmaceutical Co., Ltd.SZSE: 300086 | $373.04M | CN¥5.49 | +2.23% |
| Zhejiang Shengda Bio-Pharm Co., Ltd.SHSE: 603079 | $372.46M | CN¥13.31 | -2.20% |
| Egyptian International Pharmaceutical Industries CompanyCASE: PHAR | $367.68M | EGP114.10 | -1.47% |
| GlaxoSmithKline Pakistan LimitedKASE: GLAXO | $364.11M | PKRs316.60 | +1.20% |
| Zhejiang Xinguang Pharmaceutical Co., Ltd.SZSE: 300519 | $362.13M | CN¥15.16 | +2.29% |
| Relmada Therapeutics, Inc.NasdaqCM: RLMD | $361.61M | $3.45 | +1.62% |
Figures last refreshed Oct 11, 2026.